Alkem Laboratories Limited
ALKEM
Pozycja w akcjach
#2829
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Cena akcji
$55.22
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$6.60B
Zmiana (1 dzień)
-1.29%
Zmiana (1 rok)
-12.67%
Kraj
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategoria
Healthcare
EPS dla Alkem Laboratories Limited (ALKEM)
EPS na dzień June 2026 TTM: $1.99
Według najnowszych raportów finansowych i ceny akcji firmy Alkem Laboratories Limited, obecny EPS (TTM) wynosi $1.99. Na koniec roku 2024 firma miała EPS w wysokości $1.80, wzrost w porównaniu do do EPS z roku 2023, który wynosił $1.00.
Historia EPS dla Alkem Laboratories Limited od 2010 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $1.99 | -6.17% |
| 2025 | $2.12 | 17.57% |
| 2024 | $1.80 | 79.83% |
| 2023 | $1.00 | -44.76% |
| 2022 | $1.81 | 0.12% |
| 2021 | $1.81 | 44.74% |
| 2020 | $1.25 | 36.59% |
| 2019 | $0.92 | 13.02% |
| 2018 | $0.81 | -29.55% |
| 2017 | $1.15 | 22.89% |
| 2016 | $0.94 | 78.39% |
| 2015 | $0.52 | -14.30% |
| 2014 | $0.61 | -19.80% |
| 2013 | $0.76 | 8.82% |
| 2012 | $0.70 | 15.60% |
| 2011 | $0.61 | 38.68% |
| 2010 | $0.44 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -72.03% |
IN
|
